NCT06627309 2026-03-09Rapid dFLC Response Predict CHR in AL AmyloidosisPeking University People's HospitalRecruiting50 enrolled
NCT05889221 2024-09-05Multicenter Phase 2 Study of Subcutaneous Isatuximab Plus Bortezomib, Lenalidomide and Dexamethasone in the Treatment of Newly Diagnosed Transplant Ineligible Multiple MyelomaPoitiers University HospitalPhase NA Active not recruiting74 enrolled